The Cancer Letter

Inside information on cancer research and drug development

In Brief

NPR station broadcasts anniversary program on moonshot

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

On Jan. 12, the first anniversary of the National Cancer Moonshot Initiative, NPR’s largest member station, KQED San Francisco, aired a one-hour program, which is posted here.

Guests included:

  • Matthew Ong, reporter, The Cancer Letter

  • Deborah Mayer, professor, school of nursing and director of cancer survivorship, UNC Lineberger Comprehensive Cancer Center at UNC-Chapel Hill; member, Blue Ribbon Panel for Vice President Biden’s Cancer Moonshot

  • Jan Liphardt, associate professor of bioengineering, Stanford University; co-founder, Cancerbase.org

  • Alan Ashworth, president, UCSF Helen Diller Family Comprehensive Cancer Center; senior vice president for Cancer Services, UCSF Health Professor of Medicine

Table of Contents

YOU MAY BE INTERESTED IN

Conversation with The Cancer Letter

Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence

More than half of deaths that are not attributed to disease progression or recurrence after CAR T-cell therapy are caused by infections—an unprecedented finding that experts say marks a shift from a conventional focus on mitigating treatment-specific adverse events to including prevention and management of infections.
By Matthew Bin Han Ong
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account